Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ranaghan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bone Marrow Transplantation|September 1, 1999
Poor stem cell mobilizers--variation in response to G-CSF dose escalationT Morris, L Ranaghan, M Drake
Medical Oncology (Northwood, London, England)|January 10, 2002
Phase II trial of clarithromycin and pamidronate therapy in myelomaT C Morris, L Ranaghan, J Morrison, et al.
The Ulster Medical Journal|January 14, 1999
Outcome in Hodgkin's disease: a 20-year cohort of patientsL Ranaghan, G M Markey, T C Morris
Clinical and Laboratory Haematology|July 29, 1998
Leukaemoid monocytosis in M4 AML following chemotherapy and G-CSFL Ranaghan, M Drake, M W Humphreys, et al.
American Journal of Hematology|November 1, 1994
Bone marrow necrosisL Ranaghan, T C Morris, Z R Desai, et al.
Bone Marrow Transplantation|October 28, 2003
Prognostic value of C-reactive protein and cytokine assays for transplant-related mortalityT C M Morris, M K Magill, L Ranaghan, et al.
European Journal of Haematology|January 1, 1994
Drug-induced neutropenia due to direct effects on CFU-C--ten years of culture experienceA E Irvine, A French, A Daly, et al.
Annals of the Royal College of Surgeons of England|November 5, 2016
Survival following operative management of gastric linitis plastica compared with non-operative managementR J Thompson, L Ranaghan, R Kennedy, et al.
The Ulster Medical Journal|April 1, 1993
Myeloma--results of treatment 1986-1990P Kettle, L Ranaghan, G M Markey, et al.
British Journal of Haematology|October 23, 1997
Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring systemM Drake, L Ranaghan, T C Morris, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bone Marrow Transplantation|September 1, 1999
Poor stem cell mobilizers--variation in response to G-CSF dose escalationT Morris, L Ranaghan, M Drake
Medical Oncology (Northwood, London, England)|January 10, 2002
Phase II trial of clarithromycin and pamidronate therapy in myelomaT C Morris, L Ranaghan, J Morrison, et al.
The Ulster Medical Journal|January 14, 1999
Outcome in Hodgkin's disease: a 20-year cohort of patientsL Ranaghan, G M Markey, T C Morris
Clinical and Laboratory Haematology|July 29, 1998
Leukaemoid monocytosis in M4 AML following chemotherapy and G-CSFL Ranaghan, M Drake, M W Humphreys, et al.
American Journal of Hematology|November 1, 1994
Bone marrow necrosisL Ranaghan, T C Morris, Z R Desai, et al.
Bone Marrow Transplantation|October 28, 2003
Prognostic value of C-reactive protein and cytokine assays for transplant-related mortalityT C M Morris, M K Magill, L Ranaghan, et al.
European Journal of Haematology|January 1, 1994
Drug-induced neutropenia due to direct effects on CFU-C--ten years of culture experienceA E Irvine, A French, A Daly, et al.
Annals of the Royal College of Surgeons of England|November 5, 2016
Survival following operative management of gastric linitis plastica compared with non-operative managementR J Thompson, L Ranaghan, R Kennedy, et al.
The Ulster Medical Journal|April 1, 1993
Myeloma--results of treatment 1986-1990P Kettle, L Ranaghan, G M Markey, et al.
British Journal of Haematology|October 23, 1997
Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring systemM Drake, L Ranaghan, T C Morris, et al.
Pageof 1